Small and medium-size enterprises/SME
In recent years it has also emerged in Italy, although with a significant delay compared to all the countries of comparable size and economic importance, a significant tissue of new enterprises dedicated to biotechnology (New Biotech Companies). It is a truly innovative sector that has shown a very considerable growth rate: this segment is composed of small and medium-sized enterprises dedicated to biotechnology, both new formation (startup) and resulting from industrial or academic spin-offs. Despite being still a very young industry, bloomed despite the absence of specific support measures, it has the potential prospects for further acceleration in the growth rate, capable of creating knowledge and innovation and thus making a real contribution to the national system in terms of industry, economic return and employment.
By comparing the Italian situation with that of other European countries, where even the industry is more mature, we see a particular validity of Italian companies, ranking third in Europe by number, after Germany and the UK, both in terms of financial equilibrium (because, although, on average, under-funded, have been shown to "be able to hold up" under the weight of the crisis of recent years) and, in particular, on the potential in terms of product development.
From a quantitative point of view, Italy manufactures much more research excellence than it is normally believed, as demonstrated by the comparative figures for the country relative to the average number of publications in the fields of technology. Unfortunately, it is still lacking the transformation of research results in patents, new businesses and products and technologies on the market.
Recently, as part of the biotechnology industry have occurred Italian imposing phenomena of acquisition, merger and merger of companies operating in sectors intersected traditional biotechnological innovation (fine chemicals, pharmaceuticals, food processing): these were accompanied by the widespread creation of new small businesses in specialist vocation.
These small companies are born around with the idea of winning business and tend to occupy niches in the market development and are hardly attractive to large companies; alternatively they are engaged in R&D, highly innovative and high refresh rate, potentially interesting for big companies. The collaboration between large companies and small businesses has produced and continues to produce these positive effects and synergistic effects that are the basis of the progress of the biotechnology industry, as it is of essential conditions to achieve sufficient growth to allow playing a really competitive role.
Europe has already realized the importance of biotechnology, recognized as one of the main levers for economic growth and social development. Other Member States, such as Britain, Germany and France, are implementing concrete floors, because they glimpsed in them one of the main engines of economic progress. Italy now finds itself in a position not only to secure the possibility of recovery but, hopefully, of "distinction" in the great potential offered for creating biotech entrepreneurship. It is really important for scientific resources, human and cultural, and still widely exploited compared to other EU countries. To take full advantage of the potential for the development of innovative bio-industry in the country is essential to have a general turnaround compared to the past and to radical change the attitude towards biotechnology industry overall by national institutions. If Italy does not want to be left out of the race for innovation production at an affordable cost, it is necessary to recognize as a strategic priority for the national interest the support to creation and growth of biotech companies, as well as their integration into the European space industry and research.
For these reasons Assobiotec set itself the goal of becoming the primary point of reference for these small and medium-sized enterprises, representing the needs on an institutional and financial level and becoming a promoter of specific initiatives and services.
Contact our Small and Medium Enterprise Sector